Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells.

Breast cancer research : BCR

Volumn 7, Issue 4, 2005, Pages

  Camirand, Anne ^a   Zakikhani, Mahvash ^a   Young, Fiona ^a   Pollak, Michael ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GEFITINIB; QUINAZOLINE DERIVATIVE; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HUMAN; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; QUINAZOLINES; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 27944477029     PISSN: None     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1028     Document Type: Article

References (0)